tiprankstipranks
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market

Soleno Therapeutics (SLNO) Income Statement

Compare
746 Followers

Soleno Therapeutics Income Statement

Last quarter (Q4 2024), Soleno Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Soleno Therapeutics's net income was $-55.98M. See Soleno Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -1.96M$ -2.21M$ -2.21M$ -2.19M
Operating Expenses
$ 187.67M$ 41.38M$ 25.11M$ 32.26M$ 31.95M
Depreciation and Amortization
$ 0.00$ 1.96M$ 2.21M$ 2.21M$ 2.19M
EBITDA
$ 0.00$ -37.03M$ -21.86M$ -28.70M$ -30.00M
Operating Income
$ 0.00$ -41.38M$ -24.40M$ -31.53M$ -36.29M
Other Income/Expenses
$ 0.00$ 2.40M$ 330.00K$ 618.00K$ 11.65M
Pretax Income
$ -175.85M$ -38.99M$ -24.07M$ -30.91M$ -24.64M
Net Income
$ -175.85M$ -38.99M$ -20.32M$ -29.56M$ -15.38M
Per Share Metrics
Basic EPS
$ -4.38$ -2.36$ -2.42$ -5.56$ -3.68
Diluted EPS
$ -4.38$ -2.36$ -2.42$ -5.56$ -3.68
Weighted Average Shares Outstanding
40.18M 16.49M 8.40M 5.32M 4.17M
Weighted Average Shares Outstanding (Diluted)
40.18M 16.49M 8.40M 5.32M 4.17M
Currency in USD

Soleno Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis